Klinique Med (Thailand) Market Value
| KLINIQ Stock | 32.75 0.50 1.55% |
| Symbol | Klinique |
Klinique Med 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Klinique Med's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Klinique Med.
| 11/04/2024 |
| 12/04/2024 |
If you would invest 0.00 in Klinique Med on November 4, 2024 and sell it all today you would earn a total of 0.00 from holding The Klinique Med or generate 0.0% return on investment in Klinique Med over 30 days. Klinique Med is related to or competes with Com7 PCL, Gunkul Engineering, Sappe Public, and AP Public. More
Klinique Med Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Klinique Med's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess The Klinique Med upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 9.7 | |||
| Value At Risk | (4.10) | |||
| Potential Upside | 3.42 |
Klinique Med Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Klinique Med's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Klinique Med's standard deviation. In reality, there are many statistical measures that can use Klinique Med historical prices to predict the future Klinique Med's volatility.| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.08) | |||
| Total Risk Alpha | (0.37) | |||
| Treynor Ratio | 0.3868 |
Klinique Med Backtested Returns
Klinique Med has Sharpe Ratio of -0.0806, which conveys that the firm had a -0.0806% return per unit of risk over the last 3 months. Klinique Med exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Klinique Med's Standard Deviation of 1.96, risk adjusted performance of (0.03), and Market Risk Adjusted Performance of 0.3968 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of -0.26, which conveys not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Klinique Med are expected to decrease at a much lower rate. During the bear market, Klinique Med is likely to outperform the market. At this point, Klinique Med has a negative expected return of -0.16%. Please make sure to verify Klinique Med's potential upside, and the relationship between the total risk alpha and daily balance of power , to decide if Klinique Med performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.77 |
Almost perfect reverse predictability
The Klinique Med has almost perfect reverse predictability. Overlapping area represents the amount of predictability between Klinique Med time series from 4th of November 2024 to 19th of November 2024 and 19th of November 2024 to 4th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Klinique Med price movement. The serial correlation of -0.77 indicates that around 77.0% of current Klinique Med price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.77 | |
| Spearman Rank Test | -0.68 | |
| Residual Average | 0.0 | |
| Price Variance | 0.92 |
Klinique Med lagged returns against current returns
Autocorrelation, which is Klinique Med stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Klinique Med's stock expected returns. We can calculate the autocorrelation of Klinique Med returns to help us make a trade decision. For example, suppose you find that Klinique Med has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Klinique Med regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Klinique Med stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Klinique Med stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Klinique Med stock over time.
Current vs Lagged Prices |
| Timeline |
Klinique Med Lagged Returns
When evaluating Klinique Med's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Klinique Med stock have on its future price. Klinique Med autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Klinique Med autocorrelation shows the relationship between Klinique Med stock current value and its past values and can show if there is a momentum factor associated with investing in The Klinique Med.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Klinique Stock
Klinique Med financial ratios help investors to determine whether Klinique Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Klinique with respect to the benefits of owning Klinique Med security.